Background: Aneurysm and dissection of the ascending aorta carry the risk of life-threatening complications. The anti-protease alpha 1 antitrypsin plays an important role in the tissue protease -anti-protease equilibrium. We aim to investigate the molecular pathology of these diseases by differential proteomics and mass-spectrometric analysis. Methods: From ascending aortic wall specimens of aneurysms, acute dissections and controls, protein amounts were analysed by the differential in-gel electrophoresis (DIGE). Significantly, different spots underwent qualitative analysis by nanospray mass spectrometry. Results: Among the most significant differentially expressed protein spots in the DIGE analysis, the most notable protein identified by nanospray mass spectrometry was alpha 1 antitrypsin. This was significantly reduced in aneurysms and aortic dissections compared with controls ( p < 0.05). Western blot analysis confirmed the reduced amounts of alpha 1 antitrypsin in aortic dissections ( p = 0.008 vs controls) but not for aneurysms ( p = 0.258). By quantitative reverse transcription polymerase chain reaction (RT-PCR), mRNA level of alpha 1 antitrypsin was found to be increased in aortic dissections ( p = 0.035 vs controls), whereas in aneurysms a non-significant reduction of alpha 1 antitrypsin mRNA was present ( p = 0.123 vs controls). Conclusion: In the vascular wall of ascending aortic dissections, alpha 1 antitrypsin protein amounts are reduced compared with healthy aortas. Local alpha 1 antitrypsin deficiency in the human ascending aorta might lead to proteolytic damage easing aortic dissection. #
Background
Acute aortic dissection involving the ascending aorta (i.e., Stanford type A) is a life-threatening disease that results in a mortality rate of 50% at 48 h and 80% at 1 week if left untreated [1] . The best current treatment is emergency surgery for the replacement of the ascending aorta and, eventually, the aortic (hemi-)arch. The predisposing factors for aortic dissection are hereditary connective tissue diseases (e.g., Marfan's syndrome, Ehlers-Danlos syndrome), presence of a bicuspid aortic valve, pregnancy, coarctation of the aorta and aortic aneurysms [2] . However, in many patients with acute aortic dissection type A, the above-mentioned predisposing factors are absent. The histopathological feature frequently found in aortic dissection is medial degenerative disease. While there is extensive information related to the pathology of the classical Marfan's syndrome, including its location on chromosome 15 (encoding for fibrillin), the molecular pathology of the majority of ascending aortic dissections remains to be elucidated [3] .
Alpha 1 antitrypsin (alpha 1 proteinase inhibitor) is a serine protease inhibitor, which protects tissues from enzymes of inflammatory cells (e.g., neutrophil elastase) [4] .
In the United States, it is estimated that 59 000 patients have symptomatic chronic obstructive pulmonary disease (COPD, caused by emphysema) due to severe alpha 1 antitrypsin deficiency. In addition, alpha 1 antitrypsin exerts anti-inflammatory properties by regulating the expression of pro-inflammatory cytokines (e.g., tumour necrosis factor alpha, interleukin 6 and interleukin 8) [5] .
We aimed to investigate ascending aortic wall specimens from three different groups of patients (i.e., aneurysm, aortic dissection and controls) by differential proteomics and mass-spectrometric analysis to obtain information on changes in the protein expression.
Proteomics is a technology that explores the proteome. The proteome is the total set of proteins expressed in a given cell/tissue or organism at a given time in a certain condition. Proteomics means a systematic analysis, in an automated, large-scale manner, of all protein expression patterns and protein sequences in cells and or tissues. Proteomics involves the isolation, separation, identification and functional characterisation of all the proteins in a cell/tissue or organism. Abnormalities in protein production or function have been connected to health conditions, environment responses and several diseases. Indeed, almost all drug targets are proteins -not genes. To understand how to control environment responses and or treat a particular disease, it is necessary to identify the proteins associated with that response or disease and to understand how they function.
The classic approach of proteomics involves a separation step (typically, two-dimensional gel electrophoresis) and an identification step (in our case, nanospray mass spectrometry). The advantage of differential in-gel electrophoresis (DIGE) is that fluorescent labelling of protein extracts enables comparison of protein levels of different samples within one gel and with a high sensitivity, which detects protein amounts in the 1-ng range. After separation of the proteins, the spots are quantified (with the help of fluorescence); and those spots that are statistically different between the groups are detected and picked for qualitative analysis with mass spectrometry.
Patients and methods
Between 2001 and 2004, tissue samples from the ascending aorta of 29 male, non-Marfan patients were collected and classed into three groups: control, aneurysm and aortic dissection. In the control group (n = 10), the ascending aortic tissue was collected from the explanted recipient hearts (intact and non-aneurysmatic ascending aortic wall) during heart transplantation. In the aneurysm group (ascending aortic aneurysm requiring surgical replacement, n = 10) and aortic dissection group (acute aortic dissection type A, n = 9), the ascending aortic wall specimens were excised and collected for routine histopathological analysis by the local Institute of Pathology. One part of the tissue was immediately frozen and stored at À80 8C for further molecular biological analysis.
Patient demography is listed in Table 1 .
Sample preparation
Frozen tissue samples were homogenised in lysis buffer (8 M urea, 4% CHAPS, 30 mM Tris-HCl, pH 8.3). Mechanical lysis was achieved with an Ultra-Turrax T8 homogeniser (IKA Labortechnik Staufen, Germany) for 1 min on ice. The homogenate was centrifuged at 16 000 Â g for 10 min, and the supernatant was used for protein analysis. Protein concentration was determined using the Bradford protein assay (Bio-Rad, Hercules, CA, USA).
Pooling samples
Equal amounts of individual samples from each group were pooled.
Pool C: Control (n = 10) Pool A: Aneurysm (n = 10) Pool D: Dissection (n = 9) An internal standard was made by pooling equal amounts of each of the experimental samples.
Protein labelling for 2D differential in-gel electrophoresis (DIGE)
Pooled samples were minimally labelled with CyDye DIGE Fluors (GE Healthcare Inc., Austria) [6, 7] .
, respectively. The three dyes were designed to ensure that proteins common to each sample have the same relative mobility regardless of the dye used to tag them. CyDyes were reconstituted in anhydrous DMF to a stock solution of 1 nmol ml À1 ; the stock solution was further diluted to a working solution of 400 pmol ml À1 in DMF. Finally, 50 mg of either sample were labelled with 400 pmol dye, according to the kit instructions (GE Healthcare Inc., Austria). Labelling was performed on ice and in the dark for 30 min. The reaction was then quenched by incubating with 1 ml of 10 mM lysine on ice and in the dark for 10 min. The individually labelled samples were mixed with an equal volume of 2Â lysis buffer containing 2% DTT and 2% pharmalyte pH 3-11.
Each sample was run fourfold. The samples of each group were alternately labelled with Cy3 and Cy5, thus accounting for possible differences in intensity between the dyes. In accordance with the DIGE-recommended experimental design, a pooled internal standard containing all samples included in the experiment was prepared and labelled with CyDye DIGE Fluor Cy2 minimal dye [8, 9] . Two different labelled samples and one pooled standard were mixed. Rehydration buffer (8 M urea, 2% CHAPS, 0.5% IPG-Buffer pH 3-11, 0.002% Bromphenol blue) was added to make up the volume to 340 ml prior to isoelectric focussing (IEF).
Protein separation and detection by 2D SDS-PAGE
(poly acrylamide gel electrophoresis)
First dimension: isoelectric focussing (IEF)
Rehydration loading was used for all gels. Non-linear IPG strips 18 cm long, pH 3-11 NL (GE Healthcare Inc., Austria) were rehydrated with CyDye-labelled samples (150 mg protein in 340 ml rehydration solution per strip) overnight at room temperature using a re-swelling tray (GE Healthcare Inc., Austria). IEF was performed using the IPGphor II apparatus (GE Healthcare Inc., Austria) for a total of 40 000 Vh at 20 8C at 50 mA per strip.
Second dimension: SDS-PAGE
For the second dimension, IPG strips were then equilibrated for 15 min in equilibration buffer (50 mM Tris-HCl, 6 M urea, 30% glycerol, 2% SDS) supplemented with 1% DTT to maintain the fully reduced state of proteins, followed by 15 min in equilibration buffer supplemented with 2.5% iodoacetamide to prevent reoxidation of thiol groups during electrophoresis.
The equilibrated strips were loaded on top of the slab gels and overlaid with preheated 0.5% (w/v) agarose. The seconddimension separation was performed on 12.5% sodium dodecyl sulphate (SDS) polyacrylamide gels (Laemmli) manually cast using an Ettan Dalt six system (GE Healthcare Inc., Austria). Six parallel gels were run at 15 8C. Electrophoresis was conducted at 0.5 W per gel for 1.5 h, followed by 3 W per gel until the Bromophenol blue dye front reached the end of the gels.
Imaging
The gels were scanned directly between the glass plates using a Typhoon 9410 (GE Healthcare Inc., Austria) laser scanner. The Cy2 images were scanned using a 488-nm laser and an emission filter of 520-nm BP (band pass) 40. The Cy3 images were scanned using a 532-nm laser and an emission filter of 580-nm BP30. The Cy5 images were scanned using a 633-nm laser and a 670-nm BP30 emission filter.
Differential in-gel electrophoresis (DIGE) analysis
Image analysis was carried out with DeCyder 2D 6.5 software (GE Healthcare Inc., Austria) using the batch processor facility. The batch processor automatically analysed the scanned images first using the differential in-gel analysis (DIA) module. When spot detection and quantitation of all single gels were performed, data were transferred to the biological variation analysis (BVA) module for inter-gel analysis. DeCyder BVA processes multiple gel images, performing matching of multiple images from different gels for comparison to provide statistical data on different protein abundance levels between multiple groups. This module uses the benefits provided by the pooled internal standard experimental design by performing gel-to-gel matching on pooled internal standard images only. This process enables comparison of protein abundance between samples on different gels. A list was thus generated containing the protein spot ratio and the T-test value for each spot. Relevant spots were selected by narrowing the filter settings such that differences in the spot volume between the proteins from the different samples were !1.5 with a T-test confidence !95% (P 0.05)
Spot handling
For the proteins of interest, we generated a pick list for the Ettan Spot Picker (GE Healthcare Inc., Austria). Selected protein spots were excised from 2D gels using the Ettan Spot Picker with a 2-mm-diameter picking head and stored at À20 8C until analysed by mass spectrometry.
Western blotting
To validate the results of DIGE analysis and to confirm the results from the pools, we used an immunoblotting technique for quantification of alpha 1 antitrypsin in each of the individual samples (n = 10 controls, n = 10 aneurysms and n = 9 dissections).
The protein extracts from individual samples containing 20 mg per lane were resolved by SDS-PAGE (12%, 37.5:1 Acrylamide/bis-acrylamide; Tris-glycine), and blotted on polyvinylidene fluoride (PVDF) membrane (Hypond-P, Amersham Biosciences, GE Healthcare Inc., Austria). The membrane was blocked using phosphate-buffered solution (PBS) 0.1% Tween, 5% (w/v) skim milk powder, 10% horse serum for 2 h, and subsequently probed with the specific antibody to alpha 1 antitrypsin, 1:10 000 (Acris Antibodies R1055P) overnight at 4 8C. The membranes were washed and hybridised with anti-goat IgG peroxidase-conjugated secondary antibody 1:50000 (Sigma A 5420, Sigma Inc., Austria). The membranes were developed using the ECL-PLUS western blot analysis kit (Amersham Biosciences), according to the manufacturer's instructions. Recording and visualising were performed in an imaging system Typhoon 9410 Laser scanner (Amersham Biosciences). To serve as controls for the amount of protein loaded, the membranes were stripped out of the antibodies, re-probed with an antibody against actin (mouse-anti-actin, CHEMICON MAB 1501, 1:20 000), recorded and visualised as already described. Protein abundance was quantified using the ImageQuant 5.2 software (Amersham Biosciences).
In-gel digestion and mass-spectrometric analysis
The protein spot of interest was transferred into a 0.25-ml polyethylene sample vial and washed with two changes of 50 ml 100 mM NH 4 HCO 3 , pH 8.0 (15 min at 30 8C). The supernatant was discarded, the gel spot was shrunk by dehydration in 50 ml of 50% (v/v) acetonitrile/100 mM NH 4 HCO 3 (15 min at 30 8C) twice and dried in a vacuum centrifuge. DTT (50 ml of 10 mM) in 100 mM NH 4 HCO 3 was added (30 min at 56 8C), the supernatant was removed and 50 ml acetonitrile added. After 10-min incubation, the acetonitrile was replaced and 50 ml of 55 mM iodoacetamide in 100 mM NH 4 HCO 3 was added. After 20-min incubation at room temperature in the dark, the spot was washed with 50 ml 100 mM NH 4 HCO 3 for 5 min and shrunk by adding 150 ml acetonitrile for 15 min. After removing the supernatant, the gel piece was completely dried in a vacuum centrifuge. The gel spot was swollen in a digestion buffer containing 100 mM NH 4 HCO 3 and 0.05 mg ml À1 of trypsin (Sigma, proteomics grade) at 4 8C for 20 min. Digestion took place overnight at 37 8C. Peptides were extracted by adding 50 ml 10 mM NH 4 HCO 3 (37 8C, 15 min) and 50 ml acetonitrile (37 8C, 15 min). After collecting the supernatant, 100 ml of 10% formic acid/20% acetonitrile/20% 2-propanol was added to the gel pieces (37 8C, 10 min). The supernatants were combined, dried down to about 5 ml and stored at À20 8C.
Protein digests were analysed using an LCQ ion trap instrument (ThermoFinnigan, San Jose, CA, USA) equipped with a nanospray interface. The nanospray voltage was set at 1.6 kV, and the heated capillary was held at 200 8C. MS/MS spectra were searched against a human database using SEQUEST (LCQ BioWorks; ThermoFinnigan).
Quantitative PCR
Total RNA was extracted from tissue sections (cubes of approximately 3-mm edge length) using Trizol (Gibco, Invitrogen, Lofer, Austria). 
Statistical analysis
Data are shown as absolute numbers and percentage or median and range.
Statistical analysis of DIGE was performed using a special BVA module for inter-gel analysis (compare methods section of DIGE).
Differences between alpha 1 antitrypsin densities in the western blot analysis and real-time PCR of alpha 1 antitrypsin mRNA were analysed using the Mann-Whitney U test. The SPSS TM for Windows (SPSS 10.0) was used for analysis. A p-value <0.05 was regarded statistically significant.
Results

Protein separation and detection by 2D SDS-PAGE and DIGE analysis
In total, 3944 different spots were detected on the six gels determined by the DeCyder differential analysis (DIA) software. Inter-gel matching was performed through the inclusion of the internal standard on each gel. Those protein spots that were located on the same position in different gels were matched together and a total of 1679 were matched across all the six gels. For each spot, there is a corresponding standard abundance that can be compared across all samples. The standard abundance is the volume ratio between the internal standard and a co-detected sample from the same gel. It can be considered as the relative abundance of a protein spot. Comparison of the ratios of sample/standard, not the raw spot volumes, improves the accuracy of protein quantitation between samples from different gels.
Comparison of the relative amount of 1679 detected spots between the groups C, A and D revealed 69 spots with significant variation ( p < 0.05) (Fig. 1). 
Mass-spectrometric analysis
The most significant differentially expressed protein spots, corresponding to six different proteins, were subjected to mass spectrometry and successfully identified. The proteins identified are summarised in Table 2 . Among the six identified proteins, the most notable protein was the spot 784 corresponding to alpha 1 antitrypsin (Fig. 2) . The amounts of alpha 1 antitrypsin were significantly lower in aortic dissections ( p < 0.001) and aortic aneurysms ( p < 0.001) compared with controls.
Western blotting
To validate the results of DIGE analysis and to confirm the results from the pools, we used an immunoblotting technique for quantification of alpha 1antitrypsin in all individual samples of the three groups. Alpha 1 antitrypsin densities were significantly less in aortic dissections compared with controls ( p = 0.008), whereas the reduction in aneurysms was not significant ( p = 0.258, Fig. 3A and B) .
Real-time PCR of alpha 1 antitrypsin mRNA
On mRNA level, alpha 1 antitrypsin was significantly increased in aortic dissections compared with controls ( p = 0.035), whereas in aneurysms a non-significant reduction of alpha 1 antitrypsin mRNA was present ( p = 0.123 vs controls, Fig. 4 ).
Discussion
Aortic aneurysm is a progressive disease, with average growth rates of 0.07 cm per year for the ascending aorta [10] . To prevent the lethal complications of aortic rupture or dissection, surgery of the ascending aorta is recommended if the aortic diameter exceeds 5-5.5 cm.
Aortic dissection results in separation of the aortic medial layers driven by the blood flow. It is a life-threatening disease as malperfusion of all organs is possible. If the ascending aorta is involved, mortality is especially high because rupture with immediate exsanguination or pericardial tamponade occurs in about half of the patients 48 h after the onset of the dissection. Although aortic dissection can complicate an aortic aneurysm, it is most commonly present in aortas with a normal diameter (as it was the case in the 10 patients of our study).
Cystic medial degeneration is the most commonly found histopathology of ascending aortic aneurysms. Atherosclerosis is the leading pathology of aneurysms of the descending aorta, but not of the ascending aorta [11] . Pathophysiologically, elastin and angiotensin II can induce abdominal aortic aneurysms in animal models [12, 13] . However, little is known about the genesis of ascending aortic dissections. Mutations in transforming growth factor-b receptor type II have been shown to be associated with familial thoracic aortic aneurysms and dissections [14] . Wang et al. found vitamin K epoxide reductase complex subunit 1 haplotypes associated with aortic dissection [15] .
In our study, we found a lower amount of alpha 1 antitrypsin in the aortic wall of acute dissections compared with controls in the DIGE analysis, which was confirmed by western blotting. Alpha 1 antitrypsin is a 394 amino acid, 52-kDa glycoprotein encoded on chromosome 14q31-32.1. If the balance between proteinases and anti-proteinases is disturbed in favour of proteinases, tissue damage is the consequence. In the case of alpha 1 antitrypsin deficiency, the most frequent clinical manifestation is lung emphysema [4] . We hypothesise that the decreased amounts of alpha 1 antitrypsin in the ascending aortic wall ease proteolytic The standardised abundance graph generated by DeCyder BVA analysis. It shows the variation of the expression levels (y-axis) of alpha 1 antitrypsin among the three groups (x-axis). Each sample had four replicates. The AV-ratio (average ratio value) indicates the log standardised volume ratio between the two groups. tissue damage that weakens the arterial wall and results in either aortic dilation or aortic dissection. Eliason et al. could demonstrate that neutrophil (source of neutrophil elastase) depletion inhibits experimental abdominal aortic aneurysm formation in mice [16] . In agreement with our hypothesis, case reports exist on patients with alpha 1 antitrypsin deficiency in intracranial aneurysms, cervical artery dissection and ruptured mesenteric artery aneurysm [17, 18] . Recently, Kayrak et al. presented a case report on a patient with 'alpha 1 antitrypsin deficiency' related bullous lung disease and acute aortic dissection [19] . Our DIGE analysis also revealed a lower amount of alpha 1 antitrypsin in ascending aortic aneurysms, but this finding (in contrast to aortic dissections) could not be confirmed by western blot analysis. One possible explanation might be that we used DIGE analysis as a screening method in pooled samples and western blots for confirmation in individual samples. One may speculate that the difference of amount of alpha 1 antitrypsin becomes significant with a higher number of probes. Another aspect of our study was that differences in protein levels seemed not to be related with decreased mRNA amounts. In contrast, alpha 1 antitrypsin mRNA was even slightly increased in acute aortic dissections. As a future perspective, these data could be additional help for defining patients at risk of aortic dissection (or ascending aortic aneurysm). An augmentation therapy for patients with alpha 1 antitrypsin deficiency and lung emphysema is already in clinical practice [5] . Currently, this therapy is very expensive, but further development could possibly facilitate the treatment of this disease and associated co-morbidities.
Limitations of the study
The definition of a 'healthy ascending aorta' is not so easy, and to obtain tissue probes is even more difficult. We chose probes from heart transplant recipients of a comparable age. With regard to transplant donors, the expected age would be much lower. In addition, we selected only male patients to rule out a potential sex difference. By inspection, and according to the diameter, our controls were without pathological findings.
Conclusion
We found decreased amounts of the anti-protease alpha 1 antitrypsin protein in the vascular wall of acutely dissected human ascending aortas. This might contribute, in part, to the susceptibility of the ascending aorta to fatal dissections.
